Biomere is a leading provider of preclinical discovery services specializing in a wide range of therapeutic areas in small and large animals including awake animal MRI (Ekam Imaging). Our commitment is to provide our clients with a level of scientific expertise, quality and customer service unmatched in the industry.
Nonclinical capabilities include: pharmacokinetics, lead compound screening, proof of concept, efficacy assessment, pharmacology, mechanism of action, and early lead optimization. Biomere also provides supportive colony maintenance, backup colony support and on site room use agreements.